As the calendar turned from April to May, a big change came to the FDA. Vinay Prasad, M.D., director of the Center for Biologics Evaluation and Research, officially departed from the agency for the ...
The US Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) is again extending an invitation to biologics facilities for participation in its Regulatory Site Visit ...
The Center for Biologics Evaluation and Research (CBER) has published a list of the guidances it is considering publishing during 2026. They include guidances on chimeric antigen receptor (CAR) T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results